Clinical efficacy study of the effect of whole body vibration training at different frequencies on chronic pain in osteoarthritis of the knee

Central regulatory mechanisms underlying the effects of whole-body vibration training on chronic pain in knee osteoarthritis based on rs-fMRI

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400093570

Enrollment

Unknown

Registered

2024-12-09

Start date

2024-12-09

Completion date

Unknown

Last updated

2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis of the knee

Interventions

30Hz intervention group:Whole body vibration training frequency 30Hz

40Hz intervention group:Whole body vibration training frequency 40Hz

50Hz intervention group:Whole body vibration training frequency 50Hz

Eligibility

Sex/Gender

All

Age

50 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for this test and has had pain for more than 3 months with an NRS-11 pain score greater than or equal to 3 and less than or equal to 7; (2) 50 <= age <= 75 (weeks); (3) Meets the Kellgren-Lawrence radiologic diagnostic criteria for grades II to III; (4) Have not received medication or physical therapy for knee osteoarthritis in the last 3 months; (5) Those who can provide detailed contact information, have not migrated within six months, and are able to cooperate with follow-up visits; (6) Those who voluntarily participate in the clinical trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Kellgren-Lawrence classification: grade 0, grade I, grade IV; (2) Previously treated with knee surgery; (3) Significant trauma to the knee joint; (4) Presence of coagulation disorders, systemic or localized infection of the knee joint; (5) Congenital deformity, neuropathy, vascular lesion resulting in lower limb dysfunction; (6) Those with serious primary diseases of heart, brain, lung, liver, kidney, endocrine and hematopoietic systems; (7) Patients with a history of neurological diseases such as epilepsy, dementia, cerebral hemorrhage, cerebral infarction, brain tumor or head trauma; (8) Opioid analgesic drug abusers; (9) Those who use treatments other than those in the study that have an impact on the efficacy of the disease during the intervention or follow-up period; (10) Those who dropped out and those who were unable to complete the follow-up.

Design outcomes

Primary

Measure	Time frame
11-point numeric pain score;	—

Secondary

Measure	Time frame
The Western Ontario and McMaster University index of osteoarthritis;Time Up and Go test;	—

Countries

China

Contacts

Public ContactTian Ye

Affiliated Sport Hospital of Chengdu Sport University

284179187@163.com+86 193 0281 2267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026